Our expanded commercial manufacturing capacity can help support your large-scale manufacturing projects. We have the flexibility and scalability to meet all your manufacturing requirements. Find out more: https://hubs.li/Q02Fmrg10
Almac Pharma Services
Pharmaceutical Manufacturing
Craigavon , Non-US/Other 5,436 followers
Tailormade pharmaceutical development and commercial solutions
About us
With over 50 years’ experience, Almac Pharma Services is an established, reliable and world leading CDMO partnering with the global pharmaceutical and biotechnology industry to deliver life-changing treatment on demand. Our highly skilled teams across 4 locations across the UK, Europe and the US provide a comprehensive range of tailored, quality-led and timely solutions from early and late phase pharmaceutical development, clinical and commercial drug product manufacture, product launch through to commercial packaging and global distribution. Currently supporting client portfolios in over 65 countries, our fully integrated, end-to-end solutions are tailored to meet the needs of your unique product and ultimately the patients you serve.
- Website
-
https://www.almacgroup.com/pharmaceutical-development/
External link for Almac Pharma Services
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Craigavon , Non-US/Other
- Founded
- 1968
- Specialties
- Product Launch, Distribution Services, Commercial Manufacture, Commercial Packaging, Pharmaceutical development, and Rapid Launch Service
Updates
-
Although advancements in analytical drug substance testing are being made, the increasing diversity of the therapeutic landscape is necessitating further innovation. Read Almac's perspective of analytical testing techniques for biologics from Pavan Kunala, Almac Sciences, in Pharmaceutical Technology. https://hubs.li/Q02G9D320
-
-
From our world-class MHRA, HPRA and FDA approved facilities in the UK, Europe and the US, Almac offers dedicated, flexible, qualified GMP floor space to suit your individual requirements for tailored product development, manufacturing and packaging. Find out more: https://hubs.li/Q02FmqN50
-
-
Maciej Krause is delighted to be joining naoki miki and Kate Park at BIOPLUS-INTERPHEX KOREA. Connect with him and visit the Almac booth, L20, to find out more about how we can take your project from development, through clinical trial, and into commercialisation. https://lnkd.in/d4_ixv3D
-
-
Did you know that consolidating your CDMO activity to a single source provider can provide significant cost and time savings? Read our blog to learn more about how to maximise efficiency: https://hubs.li/Q02FNxHT0 #cdmo #blog #drugdevelopment
-
-
Our integrated CMC solutions bridge the gap between drug substance and drug product development. Working with a dedicated project team, from a single source, assures our clients of scientific continuity, enabling a smoother path through their drug development programme. Book a meeting to find out more from Maciej Krause and naoki miki at BIOPLUS-INTERPHEX KOREA next week in #Seoul. https://hubs.li/Q02FmS-b0 #BIOPLUSINTERPHEX
-
-
Terry Ernest was delighted to present during today's "Pediatric Modified Release - What’s the Problem and What are Some Solutions?" workshop at the annual Controlled Release Society Meeting in #Bologna. Thanks to everyone who attended. If you have any questions, please get in touch https://lnkd.in/eitPkRgv
-
-
Harry Lindenmuth, Vice President of Operations and Audubon Site Head, took part in the All Business Podcast hosted by the PA Chamber of Business and Industry. Listen to Harry talking about his military background, transition to the pharma industry, and Almac’s footprint in #Pennsylvania, and globally. https://hubs.li/Q02Fz_rt0
-
-
We understand the unique challenges associated with handling potent compounds. Our team of experts is equipped to handle a diverse range of API and drug products utilising state-of-the-art facilities, equipment, and technology. Find out more about our high potent API processing and manufacture capabilities for both clinical and commercial products. https://hubs.li/Q02FfCy10
-
-
Terry Ernest, Director, Manufacturing Science and Technology, will be presenting on developing medicines for children at the Controlled Release Society Annual Meeting in Bologna, Italy from 8th-12th July. Secure a meeting today and connect with Terry to find out more about developing and manufacturing paediatric medications. https://hubs.li/Q02FmpNw0
-